Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,122.13
(
0.82%
)
US TECH 100
26,140.80
(
1.43%
)
Dow Jones
49,381.10
(
-0.13%
)
Brent Oil
97.17
(
2.27%
)
Bitcoin
79,103.58
(
3.64%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: Notuncoolish post# 148566

Tuesday, 09/11/2012 11:01:54 PM

Tuesday, September 11, 2012 11:01:54 PM

Post# of 257437
We don't yet know that anybody is still alive because of bavituximab. If bavituximab shows a statistically significant overall survival benefit in a large, well-designed phase III trial, then we can be more certain that bavituximab actually increases survival.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up